Motivation for the inclusion of genetic risk factors of radiosensitivity alongside dosimetric and clinical parameters in predicting normal tissue effects

Acta Oncologica

Volumn 54, Issue 8, 2015, Pages 1230-1231

  Coates, James ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; BRAIN CANCER; BRAIN NECROSIS; CANCER RADIOTHERAPY; COST EFFECTIVENESS ANALYSIS; DATA MINING; DOSIMETRY; DRUG DOSE REDUCTION; GENETIC RISK; GENOTYPE; HEAD AND NECK CANCER; HEALTH CARE COST; HIGH RISK PATIENT; HIGH RISK POPULATION; HUMAN; LETTER; LOW RISK PATIENT; ORGANS AT RISK; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTON THERAPY; RADIATION INDUCED TISSUE TOXICITY; RADIATION INJURY; RADIOLOGICAL PARAMETERS; RADIOSENSITIVITY; RISK ASSESSMENT; RISK FACTOR; THERAPY EFFECT; TISSUE INJURY; GENETICS; PROCEDURES; RADIATION TOLERANCE; RADIOMETRY;

HUMANS; RADIATION TOLERANCE; RADIOMETRY; RISK FACTORS;

EID: 84940540607     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2014.999163     Document Type: Letter

References (8)

1. Indelicato DJ, Flampouri S, Rotondo RL, Bradley JA, Morris CG, Aldana PR, et al. Incidence and dosimetric parameters of pediatric brainstem toxicity following proton therapy. Acta Oncol 2014;53:1298-304.
2. Anderson NJ, Wada M, Schneider-Kolsky M, Rolfo M, Joon DL, Khoo V. Dose-volume response in acute dysphagia toxicity: Validating QUANTEC recommendations into clinical practice for head and neck radiotherapy. Acta Oncol 2014;53:1305-11.
3. Kerns SL, Ostrer H, Rosenstein BS. Radiogenomics: Using genetics to identify cancer patients at risk for development of adverse effects following radiotherapy. Cancer Discov 2014; 4:155-65.
4. Bentzen SM, Constine LS, Deasy JO, Eisbruch A, Jackson A, Marks LB, et al. Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): An introduction to the scientific issues. Int J Radiat Oncol Biol Phys 2010;76(3 Suppl):S3-9.
5. Naqa IE, Deasy JO, Mu Y, Huang E, Hope AJ, Lindsay PE, et al. Datamining approaches for modeling tumor control probability. Acta Oncol 2010;49:1363-73.
6. Tucker SL, Dong L, Bosch WR, Michalski J, Winter K, Mohan R, et al. Late rectal toxicity on RTOG 94-06: Analysis using a mixture Lyman model. Int J Radiat Oncol Biol Phys 2010;78:1253-60.
7. Defraene G, Van den Bergh L, Al-Mamgani A, Haustermans K, Heemsbergen W, Van den Heuvel F, et al. The benefits of including clinical factors in rectal normal tissue complication probability modeling after radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2012;82:1233-42.
8. Tucker SL, Li M, Xu T, Gomez D, Yuan X, Yu J, et al. Incorporating single-nucleotide polymorphisms into the Lyman model to improve prediction of radiation pneumonitis. Int J Radiat Oncol Biol Phys 2013;85:251-7.